These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24627109)

  • 41. SPECT and PET imaging of the dopaminergic system in Parkinson's disease.
    Brücke T; Djamshidian S; Bencsits G; Pirker W; Asenbaum S; Podreka I
    J Neurol; 2000 Sep; 247 Suppl 4():IV/2-7. PubMed ID: 11199811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroimaging and transcranial ultrasonography in Parkinson's disease.
    Mehta SH; Morgan JC; Sethi KD
    Curr Neurol Neurosci Rep; 2008 Jul; 8(4):297-303. PubMed ID: 18590613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
    Phan JA; Stokholm K; Zareba-Paslawska J; Jakobsen S; Vang K; Gjedde A; Landau AM; Romero-Ramos M
    Sci Rep; 2017 Jul; 7(1):6363. PubMed ID: 28743955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
    Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
    Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of ghrelin on the motor deficit caused by the ablation of nigrostriatal dopaminergic cells or the inhibition of striatal dopamine receptors.
    Suda Y; Kuzumaki N; Narita M; Hamada Y; Shibasaki M; Tanaka K; Tamura H; Kawamura T; Kondo T; Yamanaka A; Narita M
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1102-1108. PubMed ID: 29378186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson's disease using [
    Real CC; Doorduin J; Kopschina Feltes P; Vállez García D; de Paula Faria D; Britto LR; de Vries EF
    J Cereb Blood Flow Metab; 2019 Jun; 39(6):989-1004. PubMed ID: 29271291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [18F] FDOPA PET may confirm the clinical diagnosis of Parkinson's disease by imaging the nigro-striatal pathway and the sympathetic cardiac innervation: Proof-of-concept study.
    Kuten J; Linevitz A; Lerman H; Freedman N; Kestenbaum M; Shiner T; Giladi N; Even-Sapir E
    J Integr Neurosci; 2020 Sep; 19(3):489-494. PubMed ID: 33070528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Axonal degeneration in Parkinson's disease - Basal ganglia circuitry and D2 receptor availability.
    Pelzer EA; Melzer C; Schönberger A; Hess M; Timmermann L; Eggers C; Tittgemeyer M
    Neuroimage Clin; 2019; 23():101906. PubMed ID: 31254937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterations.
    Fu JF; Klyuzhin I; McKenzie J; Neilson N; Shahinfard E; Dinelle K; McKeown MJ; Stoessl AJ; Sossi V
    Neuroimage Clin; 2019; 23():101856. PubMed ID: 31091502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.
    Booij J; Tissingh G; Winogrodzka A; van Royen EA
    Eur J Nucl Med; 1999 Feb; 26(2):171-82. PubMed ID: 9933352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PET Imaging of Serotonin Transporters With 4-[(18)F]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts.
    Chiu CH; Li IH; Weng SJ; Huang YS; Wu SC; Chou TK; Huang WS; Liao MH; Shiue CY; Cheng CY; Ma KH
    Cell Transplant; 2016; 25(2):301-11. PubMed ID: 25994923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosine A
    Mishina M; Ishii K; Kimura Y; Suzuki M; Kitamura S; Ishibashi K; Sakata M; Oda K; Kobayashi S; Kimura K; Ishiwata K
    Synapse; 2017 Aug; 71(8):. PubMed ID: 28407307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3
    Suarez LM; Alberquilla S; García-Montes JR; Moratalla R
    J Neurosci; 2018 Apr; 38(15):3619-3630. PubMed ID: 29483281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's disease.
    Razgado-Hernandez LF; Espadas-Alvarez AJ; Reyna-Velazquez P; Sierra-Sanchez A; Anaya-Martinez V; Jimenez-Estrada I; Bannon MJ; Martinez-Fong D; Aceves-Ruiz J
    PLoS One; 2015; 10(2):e0117391. PubMed ID: 25693197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [18F]PR04.MZ PET/CT Imaging for Evaluation of Nigrostriatal Neuron Integrity in Patients With Parkinson Disease.
    Juri C; Kramer V; Riss PJ; Soza-Ried C; Haeger A; Pruzzo R; Rösch F; Amaral H; Chana-Cuevas P
    Clin Nucl Med; 2021 Feb; 46(2):119-124. PubMed ID: 33323728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off.
    Chung SJ; Lee Y; Oh JS; Kim JS; Lee PH; Sohn YH
    Parkinsonism Relat Disord; 2018 Aug; 53():96-100. PubMed ID: 29776864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.